Khalid Islam

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Morris Plains, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Khalid Islam
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Khalid Islam

Form 4 holding Director

Gain Therapeutics, Inc.

Security class
Common Stock
Shares / value
880,784
Estimated value
$879,727
Report date
09 Aug 2024
Price
$0.9988
Ownership
Indirect
Form 4 holding Director

Gain Therapeutics, Inc.

Security class
Common Stock
Shares / value
50,000
Estimated value
$49,940
Report date
09 Aug 2024
Price
$0.9988
Ownership
Direct
Form 4 holding Director

Processa Pharmaceuticals, Inc.

Security class
Restricted Stock
Shares / value
18,208
Estimated value
Report date
01 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Khalid Islam

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .